• MORE MARKET STATS

EP News Bureau

Articles By EP News Bureau

1638 Articles

Parle Elizabeth Tools opens press plant in Sanand, Ahmedabad

The inauguration function was attended by 40 pharmaceutical companies

Merck relaunches customer collaboration centres with new concept

State-of-the-art laboratories will provide full end-to-end process development support and training

‘The plant has a manufacturing capacity of 30,00,000 sq ft of panels and 45,000 doors per annum’

GMP Technical Solutions, in its continuing expansion strategy, started its new manufacturing unit (Unit-III) in Bhiwandi recently. The unit was inaugurated by R Vasudevan, its Group Managing Director. Express Pharma spoke to

‘The plant has a manufacturing capacity of 30,00,000 sq ft of panels and 45,000 doors per annum’

VTE therapeutics market set to hit $3.7 billion by 2025: GlobalData

It will represent a CAGR of 2.89 per cent

VTE therapeutics market set to hit $3.7 billion by 2025: GlobalData

Newer therapies will steer Type II diabetes market in South-East Asia

The market will see a rise from $1.7 billion in 2015 to $2.7 billion by 2022, says GBI Research

Newer therapies will steer Type II diabetes market in South-East Asia

Atrial fibrillation market will peak in 2022

The market will however see a rapid decline to $4.9 billion by 2025, says GlobalData

Atrial fibrillation market will peak in 2022

India announces new biosimilar policy to tap $35 bn global market by 2020

India has announced the revised guidelines on similar biologics to address the regulatory requirements for marketing authorisation of biologics in India. The guidelines specify the regulatory pathway regarding manufacturing p

India announces new biosimilar policy to tap $35 bn global market by 2020

Conference on pharmacovigilance held in Mumbai

It brought together drug safety experts from the lifesciences industry with an aim to discuss pharmacovigilance issues that are unique to India

CSV Workshop

A two-day in depth workshop designed to provide unique insights and authoritative debate into CSV models

CSV Workshop

Pharma Data Integrity, Regulatory and Quality conference

CPhI's 3rd Annual Data Integrity, Reliability and Quality Metrics a case study led two-day workshop

Pharma Data Integrity, Regulatory and Quality conference

Pharma Conference Series

A strategic conference series that will address the most critical issues in pharmaceutical and biopharmaceutical manufacturing in India

Pharma Conference Series

CPhI Preconnect – Day Zero

CPhI's Pre Connect Congress will bring together thought leaders under one roof to discuss on the latest trends and advancements in the Indian pharma industry

CPhI Preconnect – Day Zero

CII and Novo Nordisk India organise India Innovation Dialogue

Deliberations were held on ‘Exploring the next decade of Indian innovation’

CII and Novo Nordisk India organise India Innovation Dialogue

ACG ACPL receives EXCiPACT Certification

The certificate provides independent validation that ACG ACPL maintains excipient Good Manufacturing Practices and complies with current European Union Regulation

ACG ACPL receives EXCiPACT Certification

IPEC India hosts conference on ‘The need for total excipient control’

A host of reputed speakers spoke on various subjects that impact the excipients industry

Lupin receives FDA approval for potassium chloride extended-release capsules

It is indicated for the treatment of patients with hypokalemia, with or without metabolic alkalosis, in digitalis intoxications and in patients with hypokalemic familial periodic paralysis

Lupin receives FDA approval for potassium chloride extended-release capsules

Cystic fibrosis therapies will push Vertex ahead of GSK in respiratory market by 2022: GBI Research

The respiratory market is expected to rise considerably from $28.1 billion in 2015 to $46.6 billion by 2022, at a CAGR of 7.5 per cent

Cystic fibrosis therapies will push Vertex ahead of GSK in respiratory market by 2022: GBI Research

Strides Shasun’s Q1 FY17 pharma revenues grow 43 per cent YoY

To carve out API commodity division as increasing compliance costs cut margins

Strides Shasun’s Q1 FY17 pharma revenues grow 43 per cent YoY

Lupin, Sun Pharma, Cipla and DRL top India’s Most Reputed Pharmaceutical Brands list

The study evaluates the brand reputation by analysing media perception and consumer perceptions

Lupin, Sun Pharma, Cipla and DRL top India’s Most Reputed Pharmaceutical Brands list

Aurobindo Pharma forms JV with Tergene Biotech to develop PCV

To set up a vaccine manufacturing facility as it plans to launch its vaccine products commercially in 2018

Aurobindo Pharma forms JV with Tergene Biotech to develop PCV

PharmaLytica 2016 concludes successfully in Mumbai

It brought the pharma fraternity under one roof to witness the latest industry trends, innovations and conduct business with analytical, bio tech, lab, pharma machinery and outsourcing services

PharmaLytica 2016 concludes successfully in Mumbai

Waters recognises Dr Sunghwan Kim of Kyungpook National University

Dr Kim is an expert on developing and applying analytical techniques for assessing the impact of Polynuclear Aromatic Hydrocarbons (PAHs) in the environment and for crude oil processing

Waters recognises Dr Sunghwan Kim of Kyungpook National University

Veeva opens office in Mumbai to expand presence in APAC

The team in Mumbai will serve the needs for cloud and mobility solutions among life sciences customers throughout India, Bangladesh, Sri Lanka, and Pakistan Veeva Systems has announced the opening of its office in Mumbai,

Veeva opens office in Mumbai to expand presence in APAC

Piramal Enterprises signs agreement to acquire Ash Stevens, US CDMO for HPAPIs

The facility has approvals from US, EU, Australia, Japan, Korea, Mexico regulatory agencies

Piramal Enterprises signs agreement to acquire Ash Stevens, US CDMO for HPAPIs

Lonza to acquire InterHealth Nutraceuticals

The acquisition is expected to expand Lonza’s offerings into new areas such as cognitive and diabetic health

Lonza to acquire InterHealth Nutraceuticals

Cipla appoints Umang Vohra as MD & Global CEO; Samina Vaziralli as Executive VC

Both will take charge of their new positions from September 1, 2016

Cipla appoints Umang Vohra as MD & Global CEO; Samina Vaziralli as Executive VC

Glenmark’s announces 23.96% net profit at Rs 2267.80 million for Q1 FY 2016-17

Consolidated revenue was at Rs 19,430.52 million, recording an increase of 17.92 per cent

Glenmark’s announces 23.96% net profit at Rs 2267.80 million for Q1 FY 2016-17
Advertisement
Income Tax Calculator, Budget 2019, How to Calculate Income Tax

 

Stock Market

Advertisement
Advertisement